Polymorphism in the promoter region of the Toll-like receptor 9 gene and cervical human papillomavirus infection

Journal of General Virology

Volumn 94, Issue PART8, 2013, Pages 1858-1864

  Oliveira, Lucas Boeno ^a   Louvanto, Karolina ^b   Ramanakumar, Agnihotram V ^b   Franco, Eduardo L ^b   Villa, Luisa L ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENOTYPE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TOLL LIKE RECEPTOR 9 GENE; UTERINE CERVICITIS; VIRAL CLEARANCE;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TOLL-LIKE RECEPTOR 9; YOUNG ADULT;

EID: 84880149663     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.052811-0     Document Type: Article

References (27)

1. Carvalho, A., Pasqualotto, A. C., Pitzurra, L., Romani, L., Denning, D. W. & Rodrigues, F. (2008). Polymorphisms in Toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 197, 618-621.
2. Carvalho, A., Osório, N. S., Saraiva, M., Cunha, C., Almeida, A. J., Teixeira-Coelho, M., Ludovico, P., Pedrosa, J., Pitzurra, L. & other authors (2011). The C allele of rs5743836 polymorphism in the human TLR9 promoter links IL-6 and TLR9 up-regulation and confers increased B-cell proliferation. PLoS ONE 6, e28256.
3. Carvalho, A., Cunha, C., Almeida, A. J., Osório, N. S., Saraiva, M., Teixeira-Coelho, M., Pedreiro, S., Torrado, E., Domingues, N. & other authors (2012). The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma. Genes Immun 13, 197-201.
4. Corr, S. C. & O'Neill, L. A. (2009). Genetic variation in Toll-like receptor signalling and the risk of inflammatory and immune diseases. J Innate Immun 1, 350-357.
5. Daud, I. I., Scott, M. E., Ma, Y., Shiboski, S., Farhat, S. & Moscicki, A. B. (2011). Association between Toll-like receptor expression and human papillomavirus type 16 persistence. Int J Cancer 128, 879-886.
6. Ferguson, R., Ramanakumar, A. V., Richardson, H., Tellier, P. P., Coutlée, F., Franco, E. L. & Roger, M. (2011). Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence. Hum Immunol 72, 337-341.
7. Franco, E., Villa, L., Rohan, T., Ferenczy, A., Petzl-Erler, M., Matlashewski, G. & Ludwig-McGill S. G. (1999). Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Rev Panam Salud Publica 6, 223-233.
8. Halloran, M. E. & Struchiner, C. J. (1995). Causal inference in infectious diseases. Epidemiology 6, 142-151.
9. Hasan, U. A., Bates, E., Takeshita, F., Biliato, A., Accardi, R., Bouvard, V., Mansour, M., Vincent, I., Gissmann, L. & other authors (2007). TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J Immunol 178, 3186-3197.
10. Hasimu, A., Ge, L., Li, Q. Z., Zhang, R. P. & Guo, X. (2011). Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women. Chin J Cancer 30, 344-350.
11. Lazarus, R., Klimecki, W. T., Raby, B. A., Vercelli, D., Palmer, L. J., Kwiatkowski, D. J., Silverman, E. K., Martinez, F. & Weiss, S. T. (2003). Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 81, 85-91.
12. Lee, J. W., Choi, J. J., Seo, E. S., Kim, M. J., Kim, W. Y., Choi, C. H., Kim, T. J., Kim, B. G., Song, S. Y. & Bae, D. S. (2007). Increased Toll-like receptor 9 expression in cervical neoplasia. Mol Carcinog 46, 941-947.
13. Liu, Q., Thorland, E. C., Heit, J. A. & Sommer, S. S. (1997). Overlapping PCR for bidirectional PCR amplification of specific alleles: a rapid one-tube method for simultaneously differentiating homozygotes and heterozygotes. Genome Res 7, 389-398.
14. Lu, K. C., Yang, H. Y., Lin, Y. F., Kao, S. Y., Lai, C. H., Chu, C. M., Wu, C. C. & Su, S. L. (2011). The T-1237C polymorphism of the Toll-like receptor-9 gene is associated with chronic kidney disease in a Han Chinese population. Tohoku J Exp Med 225, 109-116.
15. Mahmud, S. M., Robinson, K., Richardson, H., Tellier, P. P., Ferenczy, A. S., Roger, M., Coutlee, F. & Franco, E. L. (2007). HLA polymorphisms and cervical human papillomavirus infection in a cohort of Montreal University students. J Infect Dis 196, 82-90.
16. Misch, E. A. & Hawn, T. R. (2008). Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci (Lond) 114, 347-360.
17. Netea, M. G., Wijmenga, C. & O'Neill, L. A. (2012). Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol 13, 535-542.
18. Ng, M. T., Van't Hof, R., Crockett, J. C., Hope, M. E., Berry, S., Thomson, J., McLean, M. H., McColl, K. E., El-Omar, E. M. & Hold, G. L. (2010). Increase in NF-kB binding affinity of the variant C allele of the Toll-like receptor 9 21237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect Immun 78, 1345-1352.
19. Novak, N., Yu, C. F., Bussmann, C., Maintz, L., Peng, W. M., Hart, J., Hagemann, T., Diaz-Lacava, A., Baurecht, H. J. & other authors (2007). Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy 62, 766-772.
20. Pandey, S., Mittal, B., Srivastava, M., Singh, S., Srivastava, K., Lal, P. & Mittal, R. D. (2011). Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility. Mol Biol Rep 38, 4715-4721.
21. Rabachini, T., Trottier, H., Franco, E. L. & Villa, L. L. (2010). Validation of dot blot hybridization and denaturing high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies. BMC Genet 11, 44.
22. Rosa, M. I., Moraes, M. V., Vuolo, F., Petronilho, F., Bozzetti, M. C., Medeiros, L. R., Igansi, C. N., Silva, F. R., Dal-Pizzol, F. & Rosa, D. D. (2012). Association of interleukin-6 in women with persistence of DNA-HPV: a nested case-control study. Arch Gynecol Obstet 285, 143-148.
23. Roszak, A., Lianeri, M., Sowíska, A. & Jagodziński, P. P. (2012). Involvement of Toll-like receptor 9 polymorphism in cervical cancer development. Mol Biol Rep 39, 8425-8430.
24. Schlecht, N. F., Kulaga, S., Robitaille, J., Ferreira, S., Santos, M., Miyamura, R. A., Duarte-Franco, E., Rohan, T. E., Ferenczy, A. & other authors (2001). Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286, 3106-3114.
25. Trottier, H. & Franco, E. L. (2006). The epidemiology of genital human papillomavirus infection. Vaccine 24 (Suppl. 1), S1-S15.
26. Vandermark, E. R., Deluca, K. A., Gardner, C. R., Marker, D. F., Schreiner, C. N., Strickland, D. A., Wilton, K. M., Mondal, S. & Woodworth, C. D. (2012). Human papillomavirus type 16 E6 and E7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization. Virology 425, 53-60.
27. Weng, Y., Wang, Y., Shi, Y., Zhou, W., Wang, H. & Wang, C. (2011). TLR9 expression and its role in chemosensitivity to DDP in human cervical cancer cells in vitro. J Huazhong Univ Sci Technolog Med Sci 31, 550-554.